查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1701906

肌萎縮側索硬化症治療市場報告（按 ALS 類型、藥物類型、診斷類型、治療、配銷通路和地區）2025 年至 2033 年

Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type, Drug Type, Diagnosis Type, Treatment, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球肌萎縮側索硬化症治療市場規模達 7.87 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 11.345 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.15%。

肌萎縮側索硬化症 (ALS) 治療是一種影響脊髓和大腦神經細胞的退化性疾病，導致肌肉控制喪失。它主要由於基因突變、免疫反應失調、化學失衡等原因所引起。 ALS 的一些常見症狀包括肌肉僵硬、肌肉抽搐、腿部或手臂無力、認知和行為變化、吞嚥困難、言語不清等。 ALS 的診斷依賴病史、身體檢查、電診斷測試和神經影像學檢查。

肌萎縮側索硬化症治療市場趨勢：

由於人們生活方式的改變和日程的繁忙，神經退化性疾病的發病率不斷上升，這主要推動了肌萎縮側索硬化症治療市場的發展。除此之外，老年人口的不斷成長也促進了市場的成長，他們更容易患上此類神經系統疾病。此外，一些非政府組織和私人組織正在採取多項舉措，提高大眾對 ALS 診斷和治療的認知。這反過來又為市場創造了積極的前景。此外，針對 ALS 的針對性和症狀治療方案的日益普及也成為重要的成長誘導因素。此外，對臨床試驗的關注度不斷提高以及用於治療 ALS 的口服藥物的更快批准也促進了市場的成長。此外，各研究機構之間日益加強的策略合作，旨在開發增強肌肉功能、免疫調節和神經保護的創新治療程序，進一步催化全球市場。未來幾年，醫療保健基礎設施的不斷升級以及翻新政策的滲透率不斷提高將繼續推動全球肌萎縮側索硬化症 (ALS) 治療市場的發展。

本報告回答的關鍵問題

  • 2024 年全球肌萎縮側索硬化症治療市場規模？ 2025 年至 2033 年期間全球肌萎縮側索硬化症治療市場的預期成長率為何？
  • 推動全球肌萎縮側索硬化症治療市場發展的關鍵因素有哪些？
  • COVID-19 對全球肌萎縮側索硬化症治療市場有何影響？
  • 根據治療方法，全球肌萎縮側索硬化症治療市場如何分佈？
  • 根據配銷通路，全球肌萎縮側索硬化症治療市場分佈如何？
  • 全球肌萎縮側索硬化症治療市場的關鍵區域有哪些？
  • 全球肌萎縮側索硬化症治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球肌萎縮側索硬化症治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：按 ALS 類型

  • 散發性 ALS
  • 家族性 ALS

第7章：市場區隔：依藥物類型

  • 上市藥品
  • 新興藥物

第8章：市場區隔：依診斷類型

  • 肌電圖
  • 磁振造影
  • 血液和尿液檢查
  • 脊椎穿刺
  • 肌肉切片

第9章：市場區隔：依處理方式

  • 藥物
  • 幹細胞療法
  • 其他

第10章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 其他

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AB Science
    • Ascend Pharmaceuticals LLC
    • BrainStorm Cell Therapeutics Inc.
    • Corestem Inc.
    • Cytokinetics Inc.
    • Eledon Pharmaceuticals Inc.
    • Ionis Pharmaceuticals Inc.
    • ITF Pharma (Italfarmaco SpA)
    • Mitsubishi Chemical Group Corpotion
    • Revalesio Corporation
    • Treeway BV
Product Code: SR112025A6057

The global amyotrophic lateral sclerosis treatment market size reached USD 787.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,134.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.15% during 2025-2033.

Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene mutation, disorganized immune response, chemical imbalance, etc. Some of the common symptoms of ALS include muscle stiffness, twitching of the muscles, weakness in the legs or arms, cognitive and behavioral changes, trouble in swallowing, slurred speech, etc. The diagnosis of ALS relies on medical history, physical examination, electrodiagnostic testing, and neuroimaging.

Amyotrophic Lateral Sclerosis Treatment Market Trends:

The rising incidences of neurodegenerative disorders due to changing lifestyle patterns and hectic schedules of the individuals are primarily driving the Amyotrophic Lateral Sclerosis Treatment treatment market. Besides this, the expanding geriatric population, who are more susceptible to such neurological ailments, is also augmenting the market growth. Furthermore, several NGOs and private organizations are undertaking numerous initiatives to increase awareness regarding the diagnosis and treatment of ALS among the masses. This, in turn, is creating a positive outlook for the market. Additionally, the growing penetration of targeted and symptomatic treatment options for ALS is acting as a significant growth-inducing factor. Moreover, the elevating focus on clinical trials and faster approval of oral drugs for ALS treatment is also bolstering the market growth. Moreover, the increasing strategic collaborations among various research institutes to develop innovative treatment procedures that aim at enhancing muscle function, immune modulation, and neuroprotection are further catalyzing the global market. In the coming years, the continuous upgradation of healthcare infrastructures along with elevating penetration of refurbishment policies will continue to drive the global amyotrophic lateral sclerosis (ALS) treatment market.

Key Market Segmentation:

Breakup by ALS Type:

  • Sporadic ALS
  • Familial ALS

Breakup by Drug Type:

  • Marketed Drugs
  • Emerging Drugs

Breakup by Diagnosis Type:

  • Electromyogram
  • MRI
  • Blood and Urine Tests
  • Spinal Tap
  • Muscle Biopsy

Breakup by Treatment:

  • Medication
  • Stem Cell Therapy
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Ascend Pharmaceuticals LLC, BrainStorm Cell Therapeutics Inc., Corestem Inc., Cytokinetics Inc., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ITF Pharma (Italfarmaco S.p.A), Mitsubishi Chemical Group Corpotion, Revalesio Corporation and Treeway B.V.

Key Questions Answered in This Report

  • 1.What was the size of the global amyotrophic lateral sclerosis treatment market in 2024?
  • 2.What is the expected growth rate of the global amyotrophic lateral sclerosis treatment market during 2025-2033?
  • 3.What are the key factors driving the global amyotrophic lateral sclerosis treatment market?
  • 4.What has been the impact of COVID-19 on the global amyotrophic lateral sclerosis treatment market?
  • 5.What is the breakup of the global amyotrophic lateral sclerosis treatment market based on the treatment?
  • 6.What is the breakup of the global amyotrophic lateral sclerosis treatment market based on the distribution channel?
  • 7.What are the key regions in the global amyotrophic lateral sclerosis treatment market?
  • 8.Who are the key players/companies in the global amyotrophic lateral sclerosis treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Amyotrophic Lateral Sclerosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by ALS Type

  • 6.1 Sporadic ALS
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Familial ALS
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Marketed Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Emerging Drugs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Diagnosis Type

  • 8.1 Electromyogram
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 MRI
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood and Urine Tests
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Spinal Tap
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Muscle Biopsy
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Treatment

  • 9.1 Medication
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stem Cell Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AB Science
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Ascend Pharmaceuticals LLC
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 BrainStorm Cell Therapeutics Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Corestem Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 Cytokinetics Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Eledon Pharmaceuticals Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Ionis Pharmaceuticals Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 ITF Pharma (Italfarmaco S.p.A)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Mitsubishi Chemical Group Corpotion
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Revalesio Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Treeway B.V.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by ALS Type (in %), 2024
  • Figure 5: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 6: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Diagnosis Type (in %), 2024
  • Figure 7: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Treatment (in %), 2024
  • Figure 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Amyotrophic Lateral Sclerosis Treatment Industry: SWOT Analysis
  • Figure 90: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by ALS Type (in Million USD), 2025-2033
  • Table 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 4: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Diagnosis Type (in Million USD), 2025-2033
  • Table 5: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Treatment (in Million USD), 2025-2033
  • Table 6: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 7: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Competitive Structure
  • Table 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Players